Related Experiment Video
Updated: May 27, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
[Self-management in anticoagulant therapy--implications for the future?].
1Leids Universitair Medisch Centrum, afd. Trombose en Hemostase, Trombosedienst Leiden en Omstreken, Leiden, the Netherlands. f.j.m.van_der_meer@lumc.nl
Self-management of oral anticoagulant therapy reduces thromboembolic events and mortality compared to standard care. Bleeding complication rates remain similar, highlighting benefits for patient outcomes.
Area of Science:
- Pharmacology
- Clinical Medicine
- Patient Management
Context:
- Oral anticoagulant therapy (OAT) is crucial for preventing thromboembolic events.
- Current OAT management relies heavily on specialized anticoagulation clinics.
- Emerging anticoagulants present new treatment paradigms.
Purpose:
- To evaluate the efficacy and safety of self-management in OAT.
- To analyze the implications of self-management findings within the Dutch healthcare system.
- To consider the impact of self-management on the adoption of novel anticoagulants.
Summary:
- A recent meta-analysis indicates that patient self-management of oral anticoagulants leads to significantly fewer thromboembolic complications.
- Mortality rates were also decreased in the self-management group.
- Importantly, the incidence of bleeding complications did not increase with self-management.
Impact:
- These findings support the integration of patient self-management strategies in OAT.
- The Dutch anticoagulation clinic model may need adaptation in light of these results.
- The introduction of new oral anticoagulants (e.g., dabigatran, rivaroxaban) could be enhanced by patient self-management protocols.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Endocarditis III: Medical Management
Mitral Stenosis III: Medical Management
